Earnings · China A-shares

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A (301211) earnings

Hubei Biocause Heilen Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-26: net profit +89.45% year on year, +2543.79% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -4.90% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-26
Period end
2026-09-30
Net profit YoY
+89.45%
Excl. one-offs YoY
+2543.79%
Net profit QoQ
-54.48%
Result
Great
Quality score
100
Quality
Sound
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-5.73%—
3 days-4.90%—
7 days+1.20%—
14 days-1.48%—

Report history

Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 2 of 8 reports (average -0.25%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-27¥39.66M+89.45%+2543.79%+11.14%0.091.74%-4.90%——
2026 interim report2026-08-25¥30.14M+62.48%+153.59%+5.43%0.071.32%+10.38%+5.02%+11.05%
2026 Q1 report2026-04-23¥9.22M-10.73%+0.24%+5.00%0.020.40%-1.86%-19.24%-17.68%
2025 annual report2026-03-31¥34.91M-61.87%-89.19%+1.67%0.081.53%+2.81%-8.33%-16.75%
2025 Q3 report2025-10-28¥20.93M-71.96%-99.14%-4.52%0.050.92%-2.93%+2.20%+5.57%
2025 interim report2025-08-01¥18.55M-72.92%-93.21%-2.93%0.060.80%-1.18%-34.16%-46.20%
2025 Q1 report2025-04-28¥10.33M-72.38%-93.03%-17.10%0.020.45%-1.97%+14.17%+10.93%
2024 annual report2025-04-24¥91.55M-48.02%-57.14%-32.75%0.223.94%-2.33%+14.62%+12.35%

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 301211

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.